VMP 42278411000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Quetiapine 300mg modified-release tablets
BNF code 0402010ABAAAXAX
Virtual Therapeutic Moiety Quetiapine
Date identifier became valid 22 Sep 2023
Previous product identifier 426401009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Quetiapine fumarate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 386850001
Strength value numerator 300.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Atrolak XL 300mg tablets (Accord-UK Ltd)
Biquelle XL 300mg tablets (Aspire Pharma Ltd)
Brancico XL 300mg tablets (Zentiva Pharma UK Ltd)
Mintreleq XL 300mg tablets (Aristo Pharma Ltd)
Quetiapine 300mg modified-release tablets (A A H Pharmaceuticals Ltd)
Quetiapine 300mg modified-release tablets (Zentiva Pharma UK Ltd)
Seroquel XL 300mg tablets (Luye Pharma Ltd)
Seroquel XL 300mg tablets (Sigma Pharmaceuticals Plc)
Sondate XL 300mg tablets (Teva UK Ltd)
Zaluron XL 300mg tablets (Fontus Health Ltd)
Virtual Medicinal Product Packs
Quetiapine 300mg modified-release tablets 30 tablet
Quetiapine 300mg modified-release tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback